IMRICOR MEDICAL SYSTEMS INC. — AGM Information 2023

Apr 5, 2023

==> picture [114 x 23] intentionally omitted <==

IMRICOR ANNUAL MEETING OF STOCKHOLDERS ONLINE MEETING GUIDE

5 April 2023 – Minneapolis, MN United States ( 6 April 2023 – Melbourne, Australia) – Imricor Medical Systems, Inc. ( Company or Imricor ) ( ASX: IMR ), advises that it will hold the annual meeting of stockholders on Friday, 12 May 2023 at 8.00am Australian Eastern Standard Time (on Thursday, 11 May 2023 at 5.00pm U.S. Central Daylight Time) ( Annual Meeting ).

The Annual Meeting will be a virtual meeting, with details included in the notice of meeting released to the ASX on 6 April 2023.

A copy of the standard Online Meeting Guide is attached to this announcement.

ENDS

Authorised for release by Steve Wedan, Executive Chair, President, and CEO.

Media and Investor Relations Contact:

Simon Hinsley simon@nwrcommunications.com.au +61 401 909 653

About Imricor

Imricor Medical Systems, Inc. (ASX:IMR) is a leading developer of innovative MRI-compatible medical devices which can be used to carry out real-time iCMR cardiac ablation procedures. Headquartered in the US, Imricor seeks to make a meaningful impact on patients, healthcare professionals, and healthcare facilities around the world by increasing the success rates and bringing down the overall costs of cardiac ablation procedures.

Imricor’s Products

Imricor Medical Systems, Inc. (ASX: IMR) | ARBN 633 106 019

400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400 | imricor.com

==> picture [114 x 23] intentionally omitted <==

Imricor is a pioneer and leader in developing MRI-compatible products for cardiac catheter ablation procedures, and believes it is the first company in the world to bring commercially viable and safe MRI-compatible products to the cardiac catheter ablation market.

The Vision-MR Ablation Catheter is the Company’s prime product offering, specifically designed to work under realtime MRI guidance, with the intent of enabling higher success rates along with a faster and safer treatment compared to conventional procedures using x-ray guided catheters. The Vision-MR Ablation Catheter has been approved in the European Union with an indication for treating type 1 atrial flutter. Imricor intends to seek approval for expanded indications in the future. The Company is also in the early stages of pursuing the required regulatory approvals to place its key products on the market in Australia and the U.S.

The Company has also obtained approval within the EU for the sale of the Advantage-MR EP Recorder/Stimulator System and its consumable product, the Vision-MR Dispersive Electrode.

Imricor sells its capital and consumable products to hospitals and clinics for use in Interventional Cardiac Magnetic Resonance Imaging (iCMR) labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed. An iCMR lab is an interventional lab that is fitted with MRI equipment for use in cardiac diagnostic and interventional procedures. The installation of iCMR labs is driven primarily by MRI equipment vendors working collaboratively with Imricor. Vendors such as Koninklijke Philips N.V. and Siemens Healthcare GmbH help to target certain sites and support the design and construction of iCMR labs for those sites.

Forward-Looking Statements

This announcement contains or may contain forward-looking statements that are based on the Company’s management’s beliefs, assumptions and expectations and on information currently available to management. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These include, without limitation, EU commercial market acceptance and EU. sales of our product as well as our expectations with respect to our ability to develop and commercialise new products. Management believes that these forward-looking statements are reasonable when made. You should not place undue reliance on forward-looking statements because they speak only as of the date when made. Imricor does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Imricor may not actually achieve the plans, projections or expectations disclosed in forward-looking statements. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.

Imricor Medical Systems, Inc. (ASX: IMR) | ARBN 633 106 019 400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400 | imricor.com

ONLINE MEETING GUIDE

GETTING STARTED

If you choose to participate online you will be able to view a live webcast of the meeting, ask the Directors questions online and submit your votes in real time. To participate online visit https://meetnow.global/au on your smartphone, tablet or computer. You will need the latest versions of Chrome, Safari, Edge or Firefox. Please ensure your browser is compatible.

TO LOG IN, YOU MUST HAVE THE FOLLOWING INFORMATION:

Australian Residents

SRN or HIN and postcode of your registered address.

Overseas Residents

SRN or HIN and country of your registered address.

Appointed Proxies

Please contact Computershare Investor Services on +61 3 9415 4024 to request your unique email invitation link prior to the meeting day.

PARTICIPATING AT THE MEETING

To participate in the online meeting, visit https://meetnow.global/au. Then enter the company name in the ‘Search for meeting’ field. Select and click on the displayed meeting.

Search for meeting

Please enter Company or Meeting Name. Enter 3 or more characters. e.g. Computershare

Or select the country where the company is based.

Australia

To register as a shareholder Select ‘Shareholder’, enter your SRN or HIN and select your country. If Australia, also enter your postcode.

==> picture [162 x 137] intentionally omitted <==

----- Start of picture text -----

Shareholder Invitation Guest
If you are a shareholder or an appointed corporate representative,
please enter the required details below.
SRN/HIN
eg. X1234567890
Country
Australia
Post Code
eg. 0123
SIGN IN
----- End of picture text -----

or To register as a proxyholder or To register as a guest To access the meeting click Select ‘Guest’ and enter on the link in the invitation your details. e-mail sent to you. Or select ‘Invitation’ and enter your Shareholder Invitation invite code provided in If you would like to attend the meeting as a Guest please provide the e-mail. your details below.

==> picture [146 x 150] intentionally omitted <==

----- Start of picture text -----

Shareholder Invitation Guest
If you would like to attend the meeting as a Guest please provide
your details below.
First Name
Last Name
Email
Company Name
SIGN IN
----- End of picture text -----

==> picture [163 x 97] intentionally omitted <==

----- Start of picture text -----

Shareholder Invitation Guest
If you have received an email invitation for this meeting, please
enter your invite code below.
Invite Cod e
Enter your invite code. e.g. G-ABCDEFG or ABCD
SIGN IN
----- End of picture text -----

1

The webcast will appear automatically once the meeting has started. If the webcast does not start automatically press the play button and ensure the audio on your computer or device is turned on.

==> picture [47 x 39] intentionally omitted <==

==> picture [232 x 210] intentionally omitted <==

----- Start of picture text -----

MR JOHN CITIZEN 500 Votes
Clip Slides

----- End of picture text -----

When the Chair declares the poll open, select the ‘Vote’ icon and the voting options will appear on your screen.

To vote, select your voting direction. A tick will appear to confirm receipt of your vote.

To change your vote, select ‘Click here to change your vote’ and press a different option to override.

Items of Business

2A Re-elect Mr John Brown as a Director

==> picture [223 x 21] intentionally omitted <==

----- Start of picture text -----

FOR AGAINST ABSTAIN
----- End of picture text -----

2B Re-elect Mr Peter Nolan as a Director

==> picture [223 x 21] intentionally omitted <==

----- Start of picture text -----

FOR AGAINST ABSTAIN
----- End of picture text -----

To ask a question select the ‘Q & A’ icon, select the topic your question relates to. Type your question into the chat box at the bottom of the screen and press ‘Send’.

To ask a verbal question, follow the instructions on the virtual meeting platform.

==> picture [224 x 111] intentionally omitted <==

----- Start of picture text -----

Your questions(s)
----- End of picture text -----

==> picture [57 x 38] intentionally omitted <==

To view meeting documents select the ‘Documents’ icon and choose the document you wish to view.

==> picture [235 x 137] intentionally omitted <==

----- Start of picture text -----

Notice of Meeting
Online User Guide
----- End of picture text -----

==> picture [225 x 63] intentionally omitted <==

----- Start of picture text -----

You may enter a question using the field below.
3 Adoption of Remuneration Report 
Enter your question here Send
24 character(s)
----- End of picture text -----

FOR ASSISTANCE

If you require assistance before or during the meeting please call +61 3 9415 4024.

2